Mayelana-umdlavuza / ukwelashwa / izidakamizwa / izinso

Izidakamizwa zivunyelwe umdlavuza wezinso (i-Renal Cell)

Leli khasi libala izidakamizwa zomdlavuza ezivunyelwe yi-Food and Drug Administration (FDA) ngomdlavuza wezinso (i-renal cell). Uhlu lufaka amagama ejwayelekile namagama ezimpawu. Amagama ezidakamizwa axhumanisa nezifinyezo ze-Cancer Information Information ze-NCI. Kungaba nezidakamizwa ezisetshenziswa kumdlavuza wezinso (i-renal cell) ezingabhalisiwe lapha.

Izidakamizwa zivunyelwe umdlavuza wezinso (i-Renal Cell)

I-Afinitor (Everolimus)

I-Afinitor Disperz (Everolimus)

I-Aldesleukin

I-Avastin (Bevacizumab)

I-Avelumab

I-Axitinib

I-Bavencio (Avelumab)

Bevacizumab

I-Cabometyx (Cabozantinib-S-Malate)

ICabozantinib-S-Malate

Everolimus

I-IL-2 (Aldesleukin)

I-Inlyta (Axitinib)

I-Interleukin-2 (Aldesleukin)

Ipilimumab

I-Keytruda (Pembrolizumab)

Lenvatinib Mesylate

I-Lenvima (Lenvatinib Mesylate)

I-Mvasi (Bevacizumab)

I-Nexavar (iSorafenib Tosylate)

UNivolumab

I-Opdivo (Nivolumab)

IPazopanib Hydrochloride

I-Pembrolizumab

I-Proleukin (Aldesleukin)

ISorafenib Tosylate

ISunitinib Malate

I-Sutent (i-Sunitinib Malate)

I-Temsirolimus

I-Torisel (Temsirolimus)

I-Votrient (Pazopanib Hydrochloride)

I-Yervoy (Ipilimumab)